Would have been interesting to see where the SP would have been had the CR been announced after todays' revenue information was released. Though the board must not have thought it was positive enough to have been a good thing for the SP. At least the numbers are going in the right direction, and if similar growth can be achieved outside the US, no reason the SP won't appreciate from here, all other things being equal.
Nova Eye Medical (EYE) Discussion, page-2366
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.010(4.35%) |
Mkt cap ! $50.34M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 22.0¢ | $170.5K | 753.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 264524 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 63154 | 2 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.0¢ |
Change
-0.010 ( 6.38 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.5¢ | 22.0¢ | 293179 | ||
| Last updated 15.58pm 07/06/2024 ? | |||||
| EYE (ASX) Chart |